
    
      The study will include two arm of patients who are scheduled for elective cardiac surgery,
      either coronary artery bypass grafting (CABG) or Valvular replacement First arm: Patients
      will take 2 g orally ascorbic acid effervescent tablets the night before cardiac surgery,
      then 1 g twice daily for 5 days after surgery in addition to their traditional medical care.
      Second arm: will not be given ascorbic acid , instead a placebo 9orange carbonated beverage)
      will be used, and will be given the rest of traditional medical care provided to the first
      arm. Inflammatory markers C- reactive protein (CRP), erythrocyte sedimentation rate (ESR) and
      differential total leukocytic count (TLC), serum urea and creatinine, ALT, AST, CK-mb,
      CK-Total, aPTT, INR, Hemoglobin, platelet count, will be assessed on day 0, 1,2,4,6
      postoperative in both arms.
    
  